Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial

Objective To show non-inferiority of trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of severe infections due to meticillin resistant Staphylococcus aureus (MRSA). Design Parallel, open label, randomised controlled trial. Setting Four acute care hospitals in Israel. Particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Mical, Bishara, Jihad, Yahav, Dafna, Goldberg, Elad, Neuberger, Ami, Ghanem-Zoubi, Nesrin, Dickstein, Yaakov, Nseir, William, Dan, Michael, Leibovici, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431679/
https://www.ncbi.nlm.nih.gov/pubmed/25977146
http://dx.doi.org/10.1136/bmj.h2219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431679/
https://www.ncbi.nlm.nih.gov/pubmed/25977146
http://dx.doi.org/10.1136/bmj.h2219

Ejemplares similares